Agenus, Inc. (AGEN)
3.58
0.00 (0.00%)
USD |
NASDAQ |
May 15, 16:00
3.58
0.00 (0.00%)
After-Hours: 20:00
Agenus Market Cap : 149.08M for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 106.96M |
| Amarin Corp. Plc | 303.84M |
| Vertex Pharmaceuticals, Inc. | 110.90B |
| Halozyme Therapeutics, Inc. | 7.961B |
| Protalix Biotherapeutics, Inc. | 159.53M |
Market Cap Related Metrics
| PE Ratio | 2.144 |
| PS Ratio | 0.9724 |
| Price | 3.58 |
| Earnings Yield | 46.63% |
| Operating PE Ratio | 15.42 |
| Normalized PE Ratio | 61.94 |